Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
10/2008
10/23/2008WO2008128161A2 Identification of cardiac specific myosin light chain kinase
10/23/2008WO2008128089A1 Use of substrates as pharmacological chaperones
10/23/2008WO2008127973A1 Cd161 ligand, pilar, for modulating activation and proliferation of t cells
10/23/2008WO2008127921A2 Primer and probe sequences for detecting chlamydia trachomatis
10/23/2008WO2008127839A2 Compositions for use in identification of bacteria
10/23/2008WO2008127675A1 Compositions and methods for retinal transduction and photoreceptor specific transgene expression
10/23/2008WO2008127655A1 Anti-alpha 6 beta 4 integrin antibodies and uses therof
10/23/2008WO2008127515A1 Compositions and method for enhancing immune responses in mammals
10/23/2008WO2008127453A2 Nucleic acid-based translation system and method for decoding nucleic acid encrypted message
10/23/2008WO2008127317A2 Alternatively spliced pre-mrna transcripts as biomarkers in idiopathic neurodegenerative diseases
10/23/2008WO2008127271A2 Interleukin -13 binding proteins
10/23/2008WO2008127248A1 Gene defects and mutant alk kinase in human solid tumors
10/23/2008WO2008125583A1 Ethynylated heterodinucleoside phosphate analogs, method for the production thereof, and use thereof
10/23/2008WO2008125116A2 Upar inhibition
10/23/2008WO2008124927A1 Sirna against thymidylate synthase and uses thereof in cancer treatment regimens
10/23/2008WO2008076981A3 Inhibitors of ll-37- mediated immune reactivity to self nucleic acids
10/23/2008WO2008070367A3 Mammalian cell-based immunoglobulin display libraries
10/23/2008WO2008067180A3 Centrosomal proteins and secretion
10/23/2008WO2008063802A3 Suppression of mitochondrial oxidative stress
10/23/2008WO2008036933A3 Compositions and methods for inhibiting expression of the hamp gene
10/23/2008WO2008036863A3 Phospholipases, nucleic acids encoding them and methods for making and using them
10/23/2008WO2008036841A3 Tripartite oligonucleotide complexes and methods for gene silencing by rna interference
10/23/2008WO2008030995A3 Use of novel pepc to produce succinate
10/23/2008WO2008028117A3 Glp-2 mimetibodies, polypeptides, compositions, methods and uses
10/23/2008WO2008025020A3 Cd30 binding agents and uses thereof
10/23/2008WO2008024242A3 Use of cd83 in combination therapies
10/23/2008WO2008021010A3 Methods for real-time quantitative pcr
10/23/2008WO2008008986A3 Methods and reagents for treatment and diagnosis of vascular disorders and age-related macular degeneration
10/23/2008WO2008005375A3 Kidney toxicity biomarkers
10/23/2008WO2007146309A3 Methods for manipulating stem cells
10/23/2008WO2007130886A3 Nutritional supplement and use thereof
10/23/2008WO2007124309A3 Methods for detecting mutations in jak2 nucleic acid
10/23/2008WO2007106707A3 Identification and engineering of antibodies with variant heavy chains and methods of using same
10/23/2008WO2007100793A3 Microarray having a base cleavable sulfonyl linker
10/23/2008WO2006099207A3 Lyase enzymes, nucleic acids encoding them and methods for making and using them
10/23/2008WO2005121352A3 Carotenoid ketolase genes with improved ketocarotenoid yield
10/23/2008US20080263730 Nucleic acid molecules and other molecules associated with plants
10/23/2008US20080263729 Stress Tolerant Organisms Expressing a Map Kinase Homologue
10/23/2008US20080263726 Short vegetative phase (SVP) gene protein for enhancing flowering time in crop plants
10/23/2008US20080263721 Genomic plant sequences and uses thereof
10/23/2008US20080263720 Methods and compositions for selecting soybean plants resistant to phytophthora root rot
10/23/2008US20080263691 Expression vector comprising nuclelotide sequences coding troponin I (TnI) protein for use in treatment and prevention of congestive heart failure
10/23/2008US20080262212 Using 40-60 mers of DNA that overlap with staggered complementary oligomers to propagate and design preferential gene sequences; directed protein evolution
10/23/2008US20080262211 Hepatitis-c virus type 4, 5 and 6
10/23/2008US20080262210 Immunostimulating Agents
10/23/2008US20080261907 siRNA blocks expression of sphingosine kinase, potentiates effect of radiation in cancer cells of breast, prostate, colorectal, lung, bladder, head and neck, intestine, ovarian, skin; reduces amount of radiation needed to decrease cancer cell viability, tumor size in vivo
10/23/2008US20080261905 Hexoses selected from tetrahydropyran; Preferred are hexitol, altritol, substituted altritols; novel modified nucleosides and nucleotides in single or double stranded oligonucleotides for RNA interference, antisense therapy; inhibit or decrease the expression of P-glycoprotein efflux pumps; cancer
10/23/2008US20080261904 Synthesized oligomers complementary to and capable of hybridizing to a selected target nucleic acid; internucleoside linking; three regions differentiated by differentially modified ribofuranosyl sugar moieties; antisense and sense oligomeric compound; inhibiting gene expression
10/23/2008US20080261903 Isolated polynucleotide encoding a Regulated in chronic obstructive pulmonary disease Kinase polypeptide; host cell; hybridization; screening; prediction, diagnosis; prognosis; chronic obstructive pulmonary disease, asthma, cancer, diseases of defective cell signaling
10/23/2008US20080261877 Albumin Fusion Proteins
10/23/2008US20080261874 Point mutations; single or double alternation of tyrosine and aspartate residues; carcinoma; AIDS; gene therapy
10/23/2008US20080261863 Pegylation of Vasoactive Intestinal Peptide (Vip) / Pituitary Adenylate Cyclase Activating Peptide (Pacap) Receptor 2 (Vpac2) Agonists and Methods of Use
10/23/2008US20080261823 Fluorescent Nucleoside Analogs That Mimic Naturally Occurring Nucleosides
10/23/2008US20080261319 Method for detecting presence of aristolochia materials in herbal products and botanicals
10/23/2008US20080261304 Interfering RNA with cholesterol moieties linked
10/23/2008US20080261290 Heat shock protein regulatory sequences for enhancing expression of heterologus genes in cells; improving transcription from exogenous genes
10/23/2008US20080261277 Circularly permuted RNA molecule carrying a stabilized biologically active RNA; antisense RNA; gene expression inhbition; ribozyme
10/23/2008US20080261269 Alleles of the oxyr gene from coryneform bacteria
10/23/2008US20080261257 Fluorescent Proteins and Related Methods and Compounds
10/23/2008US20080261252 Soluble Interleukin-1 Receptor Accessory Molecule
10/23/2008US20080261245 Antibodies, including fv molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use
10/23/2008US20080261231 Nucleotide sequences coding angiotensinogen (AGT) gene for use as evaluative tool in diagnosing pancreatic disorders; disease screening through genomic variance
10/23/2008US20080261224 PGC-1Beta, A Novel PGC-1 Homologue and Uses Therefor
10/23/2008US20080261222 Ribosomal DNA specific oligonucleotide for use in classification of preferential microorganisms
10/23/2008US20080261220 High-throughput oligonucleotide production system comprising oligonucleotide synthesizer and multiwell components
10/23/2008US20080261219 Nucleotide sequence probes for use in detecting mutation in epidermal growth factor receptor (EGFR) gene; diagnosing/prognosing cell proliferative disorders
10/23/2008US20080261214 Using cleavage polymorphism in sterol regulator element binding proteins (SREBP) gene as evaluative tool in predicting/diagnosing clinical outcomes associated with viral infection, nervous system and cholesterol disorders
10/23/2008US20080261208 For DNA sequencing
10/23/2008US20080261206 Microarray comprising bacterial-specific oligonucleotides for detection and classification of microorganisms
10/23/2008US20080261205 Method for the Simultaneous Determination of Blood Group and Platelet Antigen Genotypes
10/23/2008US20080261200 Detection of Nucleic Acid Mutations
10/23/2008US20080261198 Hemagglutinin (HA) and/or neuraminidase (NA) specific primer for use in screening for influenza infection
10/23/2008US20080261197 O retroviral protein for use as tool in detection, treatment and prevention of human immunodeficiency virus infection
10/23/2008US20080260933 Certain Plants with "No Saturate" or Reduced Saturate Levels of Fatty Acids in Seeds, and Oil Derived from the Seeds
10/23/2008US20080260903 Phospholipase
10/23/2008US20080260854 Sirna Molecules for the Treatment of Blood Vessels
10/23/2008US20080260830 suitable for regeneration, growth stimulation and differentiation of various cells, tissues and organs; growth/differentiation factors (GDFs); regeneration of connective tissue including tendon and/or ligament, periodontal or dental tissue including dental implants, neural tissue and sensory tissues
10/23/2008US20080260812 Therapeutic Medicine Containing Monoclonal Antibody Against Folate Receptor Beta (Fr-Beta)
10/23/2008US20080260789 Expressed in venom glands of spiders; polynucleotides; transgenic plant or insect
10/23/2008US20080260780 Materials and methods relating to improved vaccination strategies
10/23/2008US20080260769 Protein comprising antigenic, oligomerization, transmembrane and adhesin domains; improving membrane surface expression of heterologous protein
10/23/2008US20080260768 Streptococcus pneumoniae proteins and nucleic acid molecules
10/23/2008US20080260765 Nucleotide sequences coding human papilloma viral early and late gene for use in developing vaccine for prevention and treatment of cervical cell proliferative disorders
10/23/2008US20080260764 Variation in viral replication peptide as evaluative tool in predicting virulence in emerging influenza strains
10/23/2008US20080260760 Nucleotide sequences coding prostate-specific antigen-derived peptide for use as vaccine inntreatment of urogenital cell proliferative disorders
10/23/2008US20080260757 Bispecific Fusion Antibodies With Enhanced Serum Half-Life
10/23/2008US20080260750 Polynucleotides Encoding Acetylcholine-Gated Chloride Channel Subunits of Caenorhabditis Elegans
10/23/2008US20080260748 Desmocollin 2 (DSC2) specific immunoglobulin for use in prevention and treatment of cell proliferative disorders
10/23/2008US20080260746 Erythropoietin polypeptide for use in treatment and prevention of viral, skin, nervous system, autoimmune, cardiovascular, kidney, cell proliferative and cardiovascular disorders
10/23/2008US20080260741 Preventive and/or Therapeutic Agent for Cancer
10/23/2008US20080260739 Use of Anti-Mortalin 2 Antibody and Functional Nucleic Acid for Cancer Therapies
10/23/2008US20080260733 Humanized collagen antibodies and related methods
10/23/2008US20080260731 Fc gamma RIIIa receptor specific immunoglobulin comprising reduced fucose mdoification for use in treatment and prevention of cell proliferative and autoimmune diseases
10/23/2008US20080260729 Using RNA interference and/or endothelial growth factor specific immunoglobulins to target, treat and prevent cell proliferative disorsders
10/23/2008US20080260717 Methods for Reducing Seizure-Induced Neuronal Damage
10/23/2008US20080260698 Chimeric sindbis-western equine encephalitis virus and uses thereof
10/23/2008CA2683314A1 Isolated nucleic acid molecules corresponding to micro rna 145 (mirna-145) and their use in treating colon cancer
10/23/2008CA2653988A1 Primer and probe sequences for detecting chlamydia trachomatis
10/22/2008EP1982990A1 Cytokine receptor common gamma chain like
10/22/2008EP1982008A1 Protein c pathway associated polymorphisms as response predictors to activated protein c or protein c like compound administration
1 ... 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 ... 899